Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 11.69 | 13.54 | 11.84 | 13.48 | 14.41 |
| Operating profit | -30.94 | -27.74 | -36.64 | -30.55 | -35.26 |
| Interest | 0.16 | 0.29 | 0.53 | 0.82 | 0.54 |
| Gross profit | -9.97 | -19.58 | -31.86 | -23.61 | -21.77 |
| EPS (Rs) | -0.37 | -0.92 | -2.49 | -1.78 | -1.08 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 21.13 | 8.45 | 5.32 | 7.75 | 14.04 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 16.53 | 15.77 | 17.46 | 15.29 | 14.60 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | 20.39 | 20.50 | - | 25.17 | 25.94 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 5.71 | 5.01 | 31.02 | 3.57 | 9.14 |
| Provisions made | - | - | - | - | - |
| Depreciation | 6.50 | 6.54 | 4.39 | 4.35 | 4.17 |
| Taxation | -1.00 | - | - | -5.32 | -12.18 |
| Net profit / loss | -8.01 | -20.13 | -36.25 | -22.63 | -13.75 |
| Extra ordinary item | 7.46 | 6.00 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 21.81 | 21.81 | 14.54 | 12.73 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -264.58 | -204.92 | -309.37 | -226.64 | -244.63 |
| GPM (%) | -30.36 | -89.07 | -185.62 | -111.19 | -76.51 |
| NPM (%) | -24.40 | -91.54 | -211.22 | -106.59 | -48.34 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis